You are here:
Home
NICE Guidance
Conditions and diseases
Neurological conditions
Multiple sclerosis
icobrain ms for active relapsing–remitting multiple sclerosis
Medtech innovation briefing
Reference number:
MIB291
Published:
29 March 2022
Download (PDF)
Overview
Summary
The technology
Regulatory information
Equality considerations
Clinical and technical evidence
Expert comments
Expert commentators
Development of this briefing
Regulatory information
icobrain ms is a CE‑marked class I medical device regulated under 93/68/EEC.
Next page
Equality considerations
Previous page
The technology
Back to top